Ausgabe 4/2011
Inhalt (18 Artikel)
Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction
Phillip R. Anderson, Prospero B. Gogo, Bina Ahmed, Faye Straight, Edward F. Terrien, Matthew W. Watkins, Nader El Gharib, Harold L. Dauerman
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
Alexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, Lloyd Haskell, Dayi Hu, Russell Hull, Alexandre Mebazaa, Geno Merli, Sebastian Schellong, Alex Spyropoulos, Victor Tapson
The clinical impact of bleeding during oral anticoagulant therapy
Minna Guerrouij, Chitman S. Uppal, Ali Alklabi, James D. Douketis
Activation of mitogen activated protein kinases in post-infarcted patients
Reza Akbarzadeh Najar, Sayyed Mohammad Hossein Ghaderian, Akram Sadat Tabatabaei Panah
Effect on ex vivo platelet aggregation and in vivo cyclic flow with Na+/H+ exchange inhibition
Richard J. Gumina, Peter J. Newman, Garrett J. Gross
Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism
Martina Montagnana, Gianfranco Cervellin, Massimo Franchini, Giuseppe Lippi
Tenecteplase in the treatment of acute pulmonary thrombo-embolism
J. S. Bhuvaneswaran, Rajendra Kumar Premchand, S. S. Iyengar, Rajeev Khare, C. B. Chabra, T. N. C. Padmanabhan, S. K. Sharma, Alkesh Jain, S. A. Pandian, S. Rajdev, N. Modi, V. Kumar
High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population
Giuseppe De Luca, Monica Verdoia, Ettore Cassetti, Alon Schaffer, Chiara Cavallino, Virginia Bolzani, Paolo Marino
Fibrinogenolytic and anticoagulant activities in the tissue covering the stingers of marine stingrays Dasyatis sephen and Aetobatis narinari
Kalainesan Rajesh Kumar, Rathinam Vennila, Shankar Kanchana, Muthuvel Arumugam, Thangavel Balasubramaniam
Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial
Mary Beth Dowd, Kellie A. Vavra, Daniel M. Witt, Thomas Delate, Kerri Martinez
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Pancras C. Wong, Donald J. P. Pinto, Donglu Zhang
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis
Shaheeda Ahmed, C. Michael Gibson, Christopher P. Cannon, Sabina A. Murphy, Marc S. Sabatine
Prescription of vitamin K inhibitors in low-risk patients with atrial fibrillation
S. Granziera, G. Nante, E. Manzato, V. Pengo
Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer
Bulent Cetin, Suleyman Buyukberber, Senem Sentürk, Evrim Güzel, Ugur Coskun, Mustafa Benekli
A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke
Etheresia Pretorius, Albe C. Swanepoel, Hester M. Oberholzer, Wendy J. van der Spuy, Wiebren Duim, Pieter F. Wessels
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician
Tiago L. L. Leiria, Renato D. Lopes, Judson B. Williams, Jason N. Katz, Renato A. K. Kalil, John H. Alexander